SUSAN FERGUSON

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant|Medical SANTA ROSA BEACH, FL NPI 1659635829

General Payments — all program years on this page

$1,200.41

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 42
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $504.17 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $504.1720

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $62.221
2022 $168.463
2023 $465.5618
2024 $504.1720

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1091982733 Ipsen Biopharmaceuticals, Inc $24.53 05/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101182468 Celgene Corporation $27.87 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107098448 ABBVIE INC. $0.58 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107098450 ABBVIE INC. $27.16 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107098452 ABBVIE INC. $115.61 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107098454 ABBVIE INC. $17.28 04/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107098456 ABBVIE INC. $23.82 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137742094 Takeda Pharmaceuticals U.S.A., Inc. $25.62 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137742096 Takeda Pharmaceuticals U.S.A., Inc. $23.71 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137742098 Takeda Pharmaceuticals U.S.A., Inc. $25.70 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141753344 Merck Sharp & Dohme LLC $24.17 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146726320 Ardelyx, Inc. $21.22 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146949424 Fresenius Kabi USA, LLC $15.85 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146949426 Fresenius Kabi USA, LLC $16.50 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147017609 AIMMUNE THERAPEUTICS, INC. $20.30 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147736012 QOL Medical, LLC $19.55 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151164788 Phathom Pharmaceuticals, Inc. $16.49 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153415253 Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.45 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153606258 Salix Pharmaceuticals, a division of Bausch Health US, LLC $24.70 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153705526 Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.06 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.